The Discounted Cash Flow (DCF) valuation of Acerus Pharmaceuticals Corporation (ASP.TO) is (136.40) CAD. With the latest stock price at 0.36 CAD, the upside of Acerus Pharmaceuticals Corporation based on DCF is -37989.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.2% - 9.6% | 7.4% |
| Long-term Growth Rate | 3.0% - 4.9% | 4.0% |
| Fair Price | (1,686.35) - (77.23) | (136.40) |
| Upside | -468530.8% - -21553.3% | -37989.8% |